242 related articles for article (PubMed ID: 27939426)
1. Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer.
Li X; Zhou Y; Liu Y; Zhang X; Chen T; Chen K; Ba Q; Li J; Liu H; Wang H
EBioMedicine; 2016 Dec; 14():44-54. PubMed ID: 27939426
[TBL] [Abstract][Full Text] [Related]
2. Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers.
Zhou Y; Li X; Chen K; Ba Q; Zhang X; Li J; Wang J; Wang H; Liu H
Eur J Med Chem; 2021 Feb; 211():113000. PubMed ID: 33261896
[TBL] [Abstract][Full Text] [Related]
3. Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro.
Zhou HJ; Zhang JL; Li A; Wang Z; Lou XE
Cancer Chemother Pharmacol; 2010 May; 66(1):21-9. PubMed ID: 19756601
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy.
Chen T; Li M; Zhang R; Wang H
J Cell Mol Med; 2009 Jul; 13(7):1358-70. PubMed ID: 18466355
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway.
Liu Y; Gao S; Zhu J; Zheng Y; Zhang H; Sun H
Cancer Med; 2018 Nov; 7(11):5704-5715. PubMed ID: 30338663
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer activity of DHA on gastric cancer--an in vitro and in vivo study.
Sun H; Meng X; Han J; Zhang Z; Wang B; Bai X; Zhang X
Tumour Biol; 2013 Dec; 34(6):3791-800. PubMed ID: 23907579
[TBL] [Abstract][Full Text] [Related]
7. Study on the structure-activity relationship of dihydroartemisinin derivatives: Discovery, synthesis, and biological evaluation of dihydroartemisinin-bile acid conjugates as potential anticancer agents.
Zou X; Liu C; Li C; Fu R; Xu W; Bian H; Dong X; Zhao X; Xu Z; Zhang J; Shen Z
Eur J Med Chem; 2021 Dec; 225():113754. PubMed ID: 34399390
[TBL] [Abstract][Full Text] [Related]
8. Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer.
Wu B; Hu K; Li S; Zhu J; Gu L; Shen H; Hambly BD; Bao S; Di W
Oncol Rep; 2012 Jan; 27(1):101-8. PubMed ID: 22025319
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Dihydroartemisinin on the Malignancy and Epithelial-Mesenchymal Transition of Gastric Cancer Cells.
Li N; Zhang S; Luo Q; Yuan F; Feng R; Chen X; Yang S
Curr Pharm Biotechnol; 2019; 20(9):719-726. PubMed ID: 31187708
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
Li Y; Zhou X; Liu J; Gao N; Yang R; Wang Q; Ji J; Ma L; He Q
Life Sci; 2020 May; 248():117454. PubMed ID: 32088211
[TBL] [Abstract][Full Text] [Related]
11. Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition.
Chen C; Huang S; Chen CL; Su SB; Fang DD
Molecules; 2019 Oct; 24(20):. PubMed ID: 31623144
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin is an inhibitor of ovarian cancer cell growth.
Jiao Y; Ge CM; Meng QH; Cao JP; Tong J; Fan SJ
Acta Pharmacol Sin; 2007 Jul; 28(7):1045-56. PubMed ID: 17588342
[TBL] [Abstract][Full Text] [Related]
13. Novel artemisinin derivatives with potent anticancer activities and the anti-colorectal cancer effect by the mitochondria-mediated pathway.
Lin L; Lu W; Dai T; Chen H; Wang T; Yang L; Yang X; Liu Y; Sun D
Bioorg Chem; 2021 Jan; 106():104496. PubMed ID: 33288320
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Potentials and Mechanisms of Artemisinin and its Derivatives for Tumorigenesis and Metastasis.
Li Y; Zhou X; Liu J; Yuan X; He Q
Anticancer Agents Med Chem; 2020; 20(5):520-535. PubMed ID: 31958040
[TBL] [Abstract][Full Text] [Related]
15. Ruthenium-dihydroartemisinin complex: a promising new compound for colon cancer prevention via G1 cell cycle arrest, apoptotic induction, and adaptive immune regulation.
Wang CZ; Wan C; Li CH; Liang GG; Luo Y; Zhang CF; Zhang QH; Ma Q; Wang AH; Lager M; Jiang TL; Hou L; Yuan CS
Cancer Chemother Pharmacol; 2024 May; 93(5):411-425. PubMed ID: 38191768
[TBL] [Abstract][Full Text] [Related]
16. Artemisinin and its derivatives: a promising cancer therapy.
Kiani BH; Kayani WK; Khayam AU; Dilshad E; Ismail H; Mirza B
Mol Biol Rep; 2020 Aug; 47(8):6321-6336. PubMed ID: 32710388
[TBL] [Abstract][Full Text] [Related]
17. Selenium-enriched polysaccharides from Pyracantha fortuneana (Se-PFPs) inhibit the growth and invasive potential of ovarian cancer cells through inhibiting β-catenin signaling.
Sun Q; Dong M; Wang Z; Wang C; Sheng D; Li Z; Huang D; Yuan C
Oncotarget; 2016 May; 7(19):28369-83. PubMed ID: 27058760
[TBL] [Abstract][Full Text] [Related]
18. Artemisinin reduces cell proliferation and induces apoptosis in neuroblastoma.
Zhu S; Liu W; Ke X; Li J; Hu R; Cui H; Song G
Oncol Rep; 2014 Sep; 32(3):1094-100. PubMed ID: 25017372
[TBL] [Abstract][Full Text] [Related]
19. Novel multiarm polyethylene glycol-dihydroartemisinin conjugates enhancing therapeutic efficacy in non-small-cell lung cancer.
Dai L; Wang L; Deng L; Liu J; Lei J; Li D; He J
Sci Rep; 2014 Jul; 4():5871. PubMed ID: 25070490
[TBL] [Abstract][Full Text] [Related]
20. Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells.
Nam W; Tak J; Ryu JK; Jung M; Yook JI; Kim HJ; Cha IH
Head Neck; 2007 Apr; 29(4):335-40. PubMed ID: 17163469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
